Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.28 0.11(3.47%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.7
Mean Recommendation (last week):1.7
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:9.67
Median Target:10.00
High Target:10.00
Low Target:9.00
No. of Brokers:3

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Aug 6, 2013LaidlawInitiated Buy
Oct 28, 2009MerrimanInitiated Buy
Aug 12, 2008Piper JaffrayInitiated Buy
Apr 23, 2007Lazard CapitalInitiated Buy
Apr 10, 2007Cantor FitzgeraldInitiated Buy
Jul 10, 2006Needham & CoInitiated Buy
Upgrade
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0111
Buy0222
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.